Howard Marks’s Bausch Health BHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-1,270,000
Closed -$8.83M 148
2025
Q4
$8.83M Hold
1,270,000
0.13% 107
2025
Q3
$8.19M Hold
1,270,000
0.13% 107
2025
Q2
$8.46M Hold
1,270,000
0.15% 79
2025
Q1
$8.22M Hold
1,270,000
0.16% 83
2024
Q4
$10.2M Hold
1,270,000
0.18% 70
2024
Q3
$10.4M Hold
1,270,000
0.17% 71
2024
Q2
$8.85M Sell
1,270,000
-30,000
-2% -$227K 0.14% 63
2024
Q1
$13.8M Hold
1,300,000
0.22% 46
2023
Q4
$10.4M Hold
1,300,000
0.15% 84
2023
Q3
$10.7M Buy
+1,300,000
New +$11.2M 0.16% 74

Other funds holding BHC

Howard Marks's BHC Position: Q1 2026 in Review

Howard Marks sold out of Bausch Health (BHC) in Q1 2026, closing a stake of 1,270,000 shares — an estimated $8.83M sold.

Howard Marks first reported a position in BHC in Q3 2023 and held it in 10 quarters. The position peaked at $13.8M in Q1 2024. 228 funds tracked by Wall St. Rank hold BHC as of Q1 2026.

  • Howard Marks reported no remaining Bausch Health position as of Q1 2026 after selling out during the quarter.
  • Howard Marks sold 1,270,000 Bausch Health shares in Q1 2026, an estimated $8.83M.
  • Howard Marks first reported a position in Bausch Health in Q3 2023 and held it in 10 quarters.
  • Howard Marks's Bausch Health position peaked at $13.8M in Q1 2024.
  • 228 funds tracked by Wall St. Rank held Bausch Health as of Q1 2026.

Based on Oaktree Capital Management's 13F filing for Q1 2026, filed 15 May 2026.